Two-year cumulative incidence of hyponatremia 2.83 percent for bendroflumethiazide, 3.51 percent for hydrochlorothiazide plus RASi
Two-year cumulative incidence of hyponatremia 2.83 percent for bendroflumethiazide, 3.51 percent for hydrochlorothiazide plus RASi